Prevalence, Incidence, and Characteristics of Adverse Drug Reactions Among Older Adults Hospitalized at Mbarara Regional Referral Hospital, Uganda: A Prospective Cohort Study

References

• EdwardsIR, AronsonJK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–1259. doi:10.1016/S0140-6736(00)02799-911072960
   PubMed Web of Science ®Google Scholar
• Uganda Bureau of Statistics. Status of Older Persons in Uganda; MAKING the INVISIBLE VISIBLE. Kampala, Uganda; 2019.
   Google Scholar
• United Nations. World Population Ageing. ST/ESA/SER.A/348 ; 2013.
   Google Scholar
• World Bank. World population prospects: 2019 Revision, life expectancy at birth 2019. Available from: https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=UG. Accessed 528, 2021.
   Google Scholar
• World Health Organisation. Ageing and health 2018. Available from:https://www.who.int/news-room/fact-sheets/detail/ageing-and-health#:~:text. Accessed211, 2021.
   Google Scholar
• MangoniAA, JacksonSHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14. doi:10.1046/j.1365-2125.2003.02007.x14678335
   PubMed Web of Science ®Google Scholar
• WangY, ZhangR, ShenY, SuL, DongB, HaoQ. Prediction of chemotherapy adverse reactions and mortality in older patients with primary lung cancer through frailty index based on routine laboratory data. Clin Interv Aging. 2019;14:1187–1197. doi:10.2147/CIA.S20187331308642
   PubMed Web of Science ®Google Scholar
• KhandeparkarA, RataboliP. A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College. Perspect Clin Res. 2017;8:180. doi:10.4103/picr.PICR_132_1629109936
   PubMedGoogle Scholar
• KojimaT, MatsuiT, SuzukiY, et al. Risk factors for adverse drug reactions in older inpatients of geriatric wards at admission: multicenter study. Geriatr Gerontol Int. 2019;20:144.31829506
   PubMed Web of Science ®Google Scholar
• AguiarJP, Heitor CostaL, Alves da CostaF, LeufkensHG, MartinsAP. Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term care facilities. Clin Interv Aging. 2019;14:535–547. doi:10.2147/CIA.S19225230880934
   PubMed Web of Science ®Google Scholar
• LinHQ, WuJY, ChenML, et al. Prevalence of dyslipidemia and prediction of 10-year CVD risk among older adults living in southeast coastal regions in China: a cross-sectional study. Clin Interv Aging. 2019;14:1119–1129. doi:10.2147/CIA.S20766531354254
   PubMed Web of Science ®Google Scholar
• YadesaTM, KitutuFE, DeynoS, OgwangPE, TamukongR, AlelePE. Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: a systematic review and meta-analysis. SAGE Open Med. 2021;9:20503121211039099. doi:10.1177/2050312121103909934422271
   PubMed Web of Science ®Google Scholar
• JenningsEL, MurphyKD, GallagherP, O’MahonyD. In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs—a systematic review and meta-analysis. Age Ageing. 2020;49(6):948–958. doi:10.1093/ageing/afaa18833022061
   PubMed Web of Science ®Google Scholar
• JenningsE, MurphyK, GallagherP, O’MahonyD. Adverse drug reactions in hospitalised older adults - a systematic review. Age Ageing. 2018;47(suppl_5):v13–v60.
   Google Scholar
• AlhawassiTM, KrassI, PontLG. Prevalence and risk factors for adverse drug reactions in older adults in the acute care setting. Pharmacoepidemiol Drug Saf. 2015;24(Suppl. 1):91.
   Google Scholar
• Sari-AB-A, SheldonTA, CracknellA, TurnbullA. Sensitivity of routine system for reporting patient safety incidents in an NHS hospital: retrospective patient case note review. BMJ. 2007;334(7584):79. doi:10.1136/bmj.39031.507153.AE17175566
   PubMed Web of Science ®Google Scholar
• AngamoM, CurtainC, ChalmersYD, BereznickiL. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: a prospective cross-sectional study. PLoS One. 2017;12:e0186631. doi:10.1371/journal.pone.018663129036230
   PubMed Web of Science ®Google Scholar
• AlhawassiTM, KrassI, BajorekBV, PontLG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. 2014;9:2079–2086.25489239
   PubMed Web of Science ®Google Scholar
• BudnitzDS, LovegroveMC, ShehabN, RichardsCL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–2012. doi:10.1056/NEJMsa110305322111719
   PubMed Web of Science ®Google Scholar
• PirmohamedM, JamesS, MeakinS, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–19. doi:10.1136/bmj.329.7456.1515231615
   PubMed Web of Science ®Google Scholar
• UMC-WHO. Safety Monitoring of Medicinal Products: Guidelines for Setting Up and Running a Pharmacovigilance Centre. WHO Collaborating Centre for International Drug Monitoring; 2000:28.
   Google Scholar
• BarrowP, WallerP, WiseL. Comparison of hospital episodes with ‘drug-induced’ disorders and spontaneously reported adverse drug reactions. Br J Clin Pharmacol. 2006;61(2):233–237. doi:10.1111/j.1365-2125.2005.02554.x16433879
   PubMed Web of Science ®Google Scholar
• KatusiimeB, SemakulaD, LubingaSJ. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda. Afr Health Sci. 2015;15(4):1308–1317. doi:10.4314/ahs.v15i4.3426958036
   PubMed Web of Science ®Google Scholar
• JFDA. Guidelines for detecting & reporting adverse drug reactions: individual case safety reports for healthcare professionals, rational drug use and pharmacovigilance department. Version 1; 2014.
   Google Scholar
• ConfortiA, CostantiniD, ZanettiF, MorettiU, GrezzanaM, LeoneR. Adverse drug reactions in older patients: an Italian observational prospective hospital study. Drug Healthc Patient Saf. 2012;4:75–80. doi:10.2147/DHPS.S2928722888275
   PubMedGoogle Scholar
• AhmedB, NanjiK, MujeebR, PatelMJ. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study. PLoS One. 2014;9(11):e112133. doi:10.1371/journal.pone.011213325402452
   PubMed Web of Science ®Google Scholar
• TangiisuranB, DaviesJ, WrightJ, RajkumarC. Adverse drug reactions in a population of hospitalized very elderly patients. Drugs Aging. 2012;29:669–679.22775477
   PubMed Web of Science ®Google Scholar
• AbdNM, AzizN, HassanY, Abdulrazzaq Al-AniH, GhazaliR, AliZ. Predictors of polypharmacy and adverse drug reactions among geriatric in patients at Malaysian hospital. Healthmed. 2010;4:273–283.
   Google Scholar
• O’MahonyD, GallagherP, O’ConnorMN, ByrneS. Adverse drug reactions in older patients during hospitalisation: are they predictable?Age Ageing. 2012;41(6):771–776. doi:10.1093/ageing/afs04622456465
   PubMed Web of Science ®Google Scholar
• HarugeriAPG, RameshM, GuidoS, BasavanagowdappaH. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals. J Postgrad Med. 2011;57(3):189–195.21941055
   PubMed Web of Science ®Google Scholar
• SikdarK, DowdenJ, AlaghehbandanR, MacdonaldD, WangP, GadagV. Adverse drug reactions in elderly hospitalized patients: a 12-year population-based retrospective cohort study. Ann Pharmacother. 2012;46:960–971.22739715
   PubMed Web of Science ®Google Scholar
• De PaepeP, PetrovicM, OuttierL, Van MaeleG, BuylaertW. Drug interactions and adverse drug reactions in the older patients admitted to the emergency department. Acta Clin Belg. 2013;68(1):15–21. doi:10.2143/ACB.68.1.206271423627189
   PubMed Web of Science ®Google Scholar
• LiaoP-J, MaoC-T, ChenT-L, DengS-T, HsuK-H. Factors associated with adverse drug reaction occurrence and prognosis, and their economic impacts in older inpatients in Taiwan: a nested case–control study. BMJ Open. 2019;9(5):e026771. doi:10.1136/bmjopen-2018-026771
   PubMed Web of Science ®Google Scholar
• SnehaSG, SimhadriK, SubeeshVK, SnehaSV. Predictors of adverse drug reactions in geriatric patients: an exploratory study among cancer patients. South Asian J Cancer. 2019;8(2):130. doi:10.4103/sajc.sajc_218_1831069198
   PubMed Web of Science ®Google Scholar
• DaviesEA, O’MahonyMS. Adverse drug reactions in special populations – the elderly. Br J Clin Pharmacol. 2015;80(4):796–807. doi:10.1111/bcp.1259625619317
   PubMed Web of Science ®Google Scholar
• MurayamaH, SakumaM, TakahashiY, MorimotoT. Improving the assessment of adverse drug reactions using the Naranjo Algorithm in daily practice: the Japan Adverse Drug Events Study. Pharmacol Res Perspectives. 2018;6(1):e00373. doi:10.1002/prp2.373
   PubMed Web of Science ®Google Scholar
• FasipeO, AkhidenoP, IsahA, OwhinO. A prospective study on causality assessment rating, mortality rate, and case fatality rate for adverse drug reactions among medical inpatients at the University of Benin Teaching Hospital, Nigeria. Med J Dr DY Patil Vidyapeeth. 2019;12(5):398–407. doi:10.4103/mjdrdypu.mjdrdypu_224_18
   Google Scholar
• TangiisuranB, WrightJ, Van der CammenT, RajkumarC. Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age Ageing. 2009;38(4):358–359. doi:10.1093/ageing/afp05019420141
   PubMed Web of Science ®Google Scholar
• Uganda Bureau of Statistics. The National Population and Housing Census 2014; 2016.
   Google Scholar
• TumwikirizeWA, Ogwal-OkengJW, VernbyA, AnokbonggoWW, GustafssonLL, LundborgSC. Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda. Afr Health Sci. 2011;11(1):72–78.21572860
   PubMed Web of Science ®Google Scholar
• KigubaR, KaramagiC, BirdSM. Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients. BMJ Open. 2017;7(1):e010568. doi:10.1136/bmjopen-2015-010568
   PubMed Web of Science ®Google Scholar
• MRRHBrief History of Mbarara Regional Referral Hospital 2021. Available from: https://mbararahospital.go.ug/. Accessed 422, 2021.
   Google Scholar
• MartinE. Concise Colour Medical Dictionary. Oxford University Press; 2015.
   Google Scholar
• UpToDate Contributors. ©UpToDate; 2021.
   Google Scholar
• Committee Joint Formulary. British National Formulary; 2019.
   Google Scholar
• HandlerSM, HanlonJT, PereraS, RoumaniYF, NaceDA. Consensus list of signals to detect potential adverse drug reactions in nursing homes. J Am Geriatr Soc. 2008;56(5):808–815. doi:10.1111/j.1532-5415.2008.01665.x18363678
   PubMed Web of Science ®Google Scholar
• NaranjoCA, BustoU, SellersEM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. doi:10.1038/clpt.1981.1547249508
   PubMed Web of Science ®Google Scholar
• World Health Organisation. ICD-11 for mortality and morbidity statistics; 2020. Available from: https://icd.who.int/browse11/l-m/en. Accessed 1116, 2020.
   Google Scholar
• RawlinsMD. Clinical pharmacology adverse reactions to drugs. Br Med J. 1981;282(6268):974–976. doi:10.1136/bmj.282.6268.9746781682
   PubMed Web of Science ®Google Scholar
• AronsonJK, FernerRE. Joining the DoTS: new approach to classifying adverse drug reactions. BMJ. 2003;327(7425):1222–1225. doi:10.1136/bmj.327.7425.122214630763
   PubMed Web of Science ®Google Scholar
• HartwigSC, SiegelJ, SchneiderPJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229–2232.1524068
   PubMedGoogle Scholar
• SchumockG, ThorntonP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538.10118597
   PubMedGoogle Scholar
• World Health Organisation. WHO Collaborating Centre for Drug Statistics Methodology; 2020. Available from:https://www.whocc.no/atc_ddd_index/. Accessed 518, 2021.
   Google Scholar
• Association WM. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Bull World Health Organ. 2001;79(4):373.11357217
   PubMed Web of Science ®Google Scholar
• SikdarKC, DowdenJ, AlaghehbandanR, MacDonaldD, PeterP, GadagV. Adverse drug reactions in elderly hospitalized patients: a 12-year population-based retrospective cohort study. Ann Pharmacother. 2012;46(7–8):960–971.22739715
   PubMed Web of Science ®Google Scholar
• OnderG, PetrovicM, TangiisuranB, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. JAMA Intern Med. 2010;170(13):1142–1148.
   Web of Science ®Google Scholar
• DormannH, KrebsS, Muth-SelbachU, et al. Adverse drug reactions in patients with gastroenterological diseases: does age increase the risk?Aliment Pharmacol Ther. 2001;15(2):171–180. doi:10.1046/j.1365-2036.2001.00922.x11148434
   PubMed Web of Science ®Google Scholar
• GalliT, ReisW, AndrzejevskiV. Potentially inappropriate prescribing and the risk of adverse drug reactions in critically ill older adults. Pharm Pract (Granada). 2016;14:818. doi:10.18549/PharmPract.2016.04.81828042352
   PubMedGoogle Scholar
• HarugeriA, ParthasarathiG, MadhanR, GuidoS, BasavanagowdappaH. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals. J Postgrad Med. 2011;57:189–195. doi:10.4103/0022-3859.8520121941055
   PubMed Web of Science ®Google Scholar
• MaigetterK, PollockAM, KadamA, WardK, WeissMG. Pharmacovigilance in India, Uganda and South Africa with reference to WHO’s minimum requirements. Int J Health Policy Manage. 2015;4(5):295–305. doi:10.15171/ijhpm.2015.55
   PubMed Web of Science ®Google Scholar
• AngamoMT, ChalmersL, CurtainCM, BereznickiLRE. Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Safety. 2016;39(9):847–857. doi:10.1007/s40264-016-0444-727449638
   PubMed Web of Science ®Google Scholar
• KongkaewC, NoyceP, AshcroftD. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42:1017–1025. doi:10.1345/aph.1L03718594048
   PubMed Web of Science ®Google Scholar
• GraySL, SagerM, LesticoMR, JalaluddinM. Adverse drug events in hospitalized elderly. J Gerontol. 1998;53A(1):M59–M64. doi:10.1093/gerona/53A.1.M59
   Google Scholar
• RawatRS. Evaluation of potentially inappropriate medication use and risk of adverse drug reactions in hospitalized older adults: an observational study in a tertiary care hospital. Int J Pharm Res. 2018;11(2):79–85.
   Google Scholar
• GurwitzJH, FieldTS, HarroldLR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107–1116. doi:10.1001/jama.289.9.110712622580
   PubMed Web of Science ®Google Scholar
• OgoinaD, ObiakoRO, MuktarHM, et al. Morbidity and mortality patterns of hospitalised adult HIV/AIDS patients in the era of highly active antiretroviral therapy: a 4-year retrospective review from Zaria, Northern Nigeria. AIDS Res Treat. 2012;2012:940580. doi:10.1155/2012/94058023019521
   PubMedGoogle Scholar
• Namme LumaH, DouallaM-S, ChoukemS-P, et al. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study. Pan Afr Med J. 2012;12:87.23077708
   PubMedGoogle Scholar